Top 8 Venture Capital Firms for Health Diagnostics Startups

For founders in Health Diagnostics, preparing to raise capital means finding investors who truly understand your work. The right partner brings more than just money; they offer expertise in the specific challenges of medtech, biotech, and life sciences, from clinical trials to market entry.

To help you find them, our team at Rho has curated this overview of the top venture capital firms in the space. This guide is designed to give you a clear picture of the key investors so you can focus your fundraising efforts.

Actively raising? You can now access non-dilutive funding options like venture debt and credit lines through Rho Capital. Rho also provides access to business banking, corporate cards, and bill pay—all built for startup teams moving fast.

Key Takeaways

• For Health Diagnostics startups, securing venture funding provides the necessary capital and specialized guidance to move through complex stages like clinical trials and regulatory approvals.
• Leading venture capital firms in the Health Diagnostics sector, such as Genoa Ventures, SmartGateVC, Catalyst Health Ventures, and StartUp Health, are notable backers of innovative companies in this field.
• Whether you are actively fundraising or have just closed a round, Rho helps you manage your new capital with integrated business banking, corporate cards, and automated bill pay.

Which VC Firms in Health Diagnostics Are Right for Your Stage?

Knowing who to talk to is critical, whether your company is in its early stages or preparing for an exit. Here is a quick overview of venture capital firms that invest in Health Diagnostics, organized by their preferred investment stage.

Pre-seed and Seed VC Firms in Health Diagnostics

Pre-seed and seed funding is the earliest capital you'll raise, designed to help turn an idea into a viable product and achieve initial market validation. Among the diagnostics seed stage VC firms that focus here are SmartGateVC, Leap Venture Studio, and Boutique Venture Partners.

Early Stage VC Firms in Health Diagnostics

Early-stage funding, typically Series A and B, is for companies with a market-ready product and early revenue, providing the capital needed to scale your team and commercial efforts. Many life science venture capital firms specialize in this phase, including Boston-based Catalyst Health Ventures and Genoa Ventures.

Late Stage VC Firms in Health Diagnostics

Late-stage rounds are for established companies with strong market traction, providing significant capital for scaling globally, making acquisitions, or preparing for an exit. Firms like Takeda Ventures and Broadview Ventures are active in this space, often supporting companies through to an IPO or M&A.

Once you've secured your funding, Rho’s integrated financial platform helps you manage and deploy that capital efficiently with tools like business banking, corporate cards, and automated bill pay.

It's also worth noting that many venture capital firms are stage-agnostic, investing across the startup lifecycle from seed to exit.

Here is a closer look at the top VC firms investing in Health Diagnostics. We've included key details on their investment stages, geographic focus, and what makes each firm a strong potential partner for founders like you.

1. Genoa Ventures

Genoa Ventures is a venture capital firm that invests in early-stage companies at the intersection of biology and technology. Based in San Francisco, they back founders who are building foundational platforms and tools for the life sciences industry.

The firm has a strong record of guiding companies to major outcomes, including the IPO of CRISPR-focused Caribou Biosciences and the acquisition of bio-manufacturing company Zymergen. Their portfolio demonstrates a clear focus on technically complex fields like genomics, diagnostics, and synthetic biology.

Genoa Ventures is an ideal partner for founders with deep scientific expertise who are building category-defining businesses. They are well-suited for teams seeking investors who understand the long-term vision and can support them from the early stages through to a significant exit.

• Investment stages: Seed, early, and late-stage venture
• Industries of focus: Life Science, Biotechnology, Health Diagnostics, Genetics, Bioinformatics
• Geographical presence: San Francisco, California
• Founded: 2014
• Notable portfolio companies: Caribou Biosciences, Zymergen, Mission Bio
• Portfolio size: 35 investments

As you prepare your fundraising strategy, Rho Capital can help you explore non-dilutive financing like venture debt to complement your equity round. You can refer to their website here.

2. SmartGateVC

SmartGateVC is a pre-seed and seed-stage firm based in Southern California and Armenia that invests in companies working on frontiers advanced by artificial intelligence. Their focus includes life sciences, physical sciences, and brain-computer interfaces, making them a key investor for technically-driven startups.

The firm has a clear preference for companies where AI is a core component, with portfolio successes like Krisp and SuperAnnotate highlighting this theme. They support founders building deep technology in specialized areas, from AI-powered drug discovery with Deep Origin to multi-cloud security with Britive.

SmartGateVC is a strong match for founders with a deep technical background, particularly in AI, who are building businesses in complex sectors like Health Diagnostics. If you are at the pre-seed or seed stage and need a partner who understands deep tech, they are worth considering.

As you prepare for these early-stage conversations, Rho Capital can help you explore non-dilutive financing to strengthen your position.

• Investment stages: Seed, Early Stage Venture
• Industries of focus: Artificial Intelligence (AI), Bioinformatics, Health Diagnostics, Medical Device, Cyber Security
• Geographical presence: Los Angeles, California
• Founded: 2017
• Notable portfolio companies: SuperAnnotate, Krisp, Deep Origin, Britive
• Portfolio size: 28 investments

You can refer to their website here.

3. Catalyst Health Ventures

Catalyst Health Ventures is a Boston-based firm that invests in companies developing novel solutions for unmet healthcare needs. They concentrate on medical devices, health diagnostics, and other related technologies that can make a direct impact on patient outcomes.

The firm’s portfolio shows a clear focus on backing companies with tangible products that solve specific clinical problems, such as Sera Prognostics' test for preterm birth risk. Their track record, which includes guiding Augmenix to a major acquisition by Boston Scientific, shows their ability to support founders toward significant exits.

This firm is a strong match for founders in the medical device and health diagnostics fields, particularly those with a clear strategy for regulatory approval and market entry. As you prepare your pitch for firms like Catalyst, Rho Capital can help you secure non-dilutive financing to strengthen your position.

• Investment stages: Seed, Early Stage Venture, Late Stage Venture
• Industries of focus: Health Care, Health Diagnostics, Medical Device
• Geographical presence: Boston, Massachusetts
• Founded: 2008
• Notable portfolio companies: Augmenix, Sera Prognostics, Kaleidoscope Innovation
• Portfolio size: 46 investments

You can refer to their website here.

4. StartUp Health

StartUp Health is a New York-based firm with a global mission to back founders, whom they call "Health Transformers," working on ambitious healthcare goals. They invest across a wide spectrum of health-related industries, from biotechnology to digital health.

The firm's large portfolio of over 390 companies points to a community-driven model that supports a wide range of ventures. Their portfolio includes notable companies like Bigfoot Biomedical, which has launched its diabetes management system, and Cyclica, an AI drug-discovery company that had a successful exit.

StartUp Health is a good match for early-stage founders with bold, long-term visions for solving major healthcare challenges. If you value being part of a large, global community of entrepreneurs, their platform-oriented approach could be a strong fit.

Once you secure funding from a partner like StartUp Health, our team at Rho can help you manage it with integrated banking, corporate cards, and payment automation.

• Investment stages: Seed, Early Stage Venture, Grant
• Industries of focus: Health Care, Health Diagnostics, Biotechnology, Medical Device, Personal Health
• Geographical presence: New York, New York (with a global investment focus)
• Founded: 2011
• Notable portfolio companies: Bigfoot Biomedical, Cyclica, Tia, Human API
• Portfolio size: 390 investments

You can refer to their website here.

5. Broadview Ventures

Broadview Ventures is a Boston-based firm dedicated to funding technology solutions for cardiovascular and neurovascular diseases. Their investments support companies creating new devices, diagnostics, and therapeutics in this specialized field.

The firm’s portfolio shows a strong focus on companies with clear commercial paths, including Lyra Therapeutics, which went public, and Ischemia Care, which launched a diagnostic blood test. This signals their interest in businesses that can move from development to market-ready products.

Broadview Ventures is an excellent fit for founders with deep expertise in cardiovascular or neurovascular science. If your company has a well-defined product and a clear strategy for regulatory approval and market entry, they could be a valuable partner.

As you prepare to approach investors like Broadview, our team at Rho can help you access non-dilutive financing options like venture debt to strengthen your financial position.

• Investment stages: Seed, Early Stage Venture, Late Stage Venture, Private Equity
• Industries of focus: Health Diagnostics, Life Science, Medical Device, Therapeutics
• Geographical presence: Boston, Massachusetts
• Founded: 2008
• Notable portfolio companies: Lyra Therapeutics, Herantis Pharma, Ischemia Care, Cardiosense
• Portfolio size: 74 investments

You can refer to their website here.

6. Leap Venture Studio

Leap Venture Studio is a Los Angeles-based accelerator that invests in early-stage startups innovating within the pet care industry. They support companies creating new products and services across the pet ecosystem, from nutrition to veterinary care.

The firm operates as an accelerator, which points to a hands-on approach with structured support for its portfolio companies. Their investments, including plant-based food company Wild Earth and diagnostics leader AnimalBiome, show a clear interest in consumer brands and tech-enabled pet health solutions.

Leap Venture Studio is a strong fit for founders in the pet care space, especially those at the seed or early stages who would benefit from an accelerator program. If your company is focused on pet health diagnostics, nutrition, or tech-driven services, their specialized network could be a valuable asset.

As you prepare for these early-stage conversations, Rho Capital can help you explore non-dilutive financing to strengthen your position.

• Investment stages: Seed, Early Stage Venture
• Industries of focus: Pet, Health Diagnostics, Nutrition, Veterinary, Service Industry
• Geographical presence: Los Angeles, California
• Founded: 2018
• Notable portfolio companies: Wild Earth, Smalls, AnimalBiome, Barkibu
• Portfolio size: 43 investments

You can refer to their website here.

7. Boutique Venture Partners

Boutique Venture Partners is a Palo Alto firm that specializes in early-stage investments across healthcare and life sciences. They support companies developing new technologies in fields from therapeutics to medical devices.

Their portfolio includes companies that have secured major strategic partnerships and significant funding, like miRecule's collaboration with Sanofi and Mitra Chem's Series B led by General Motors. This shows a focus on businesses with strong technical validation and clear commercial pathways.

The firm is a good match for founders with deep technical expertise who are building companies in complex areas like biotechnology, genetics, and health diagnostics. As you prepare for these early-stage conversations, Rho Capital can help you explore non-dilutive financing to strengthen your position.

• Investment stages: Seed, Early Stage Venture
• Industries of focus: Health Care, Life Science, Health Diagnostics, Medical Device, Biotechnology, Therapeutics
• Geographical presence: Palo Alto, California
• Founded: 2020
• Notable portfolio companies: miRecule, Mitra Chem, Zeda, Genalyte
• Portfolio size: 24 investments

You can refer to their website here.

8. Takeda Ventures

Takeda Ventures is the corporate venture capital arm of Takeda, a global biopharmaceutical company. From their base in San Diego, they invest in high-potential therapeutic and platform-based companies around the world.

The firm backs companies with strong scientific foundations, demonstrated by portfolio successes like NGM Biopharmaceuticals and Avidity Biosciences, both of which had successful IPOs. Their focus is on early and late-stage ventures that can achieve significant clinical and commercial milestones.

Takeda Ventures is an ideal partner for founders developing novel therapeutics or platform technologies with clear paths to market. As you prepare to approach a corporate venture firm like Takeda, our team at Rho can help you explore non-dilutive financing to strengthen your balance sheet.

• Investment stages: Early and late-stage venture
• Industries of focus: Therapeutics, Health Diagnostics, Financial Services
• Geographical presence: San Diego, California
• Founded: 2001
• Notable portfolio companies: NGM Biopharmaceuticals, Avidity Biosciences, Be Biopharma, Obsidian Therapeutics
• Portfolio size: 98 investments

You can refer to their website here.

What This Tells Us About The VC Scene for Health Diagnostics Companies

This review of investors shows that companies in health diagnostics have access to a broad and active field of funders. You’ll find firms focused on every stage, from early-stage specialists to partners who can support you through later rounds. This balance indicates that capital is available, regardless of your company's current stage.

While investors are geographically concentrated in major US hubs like California and Boston, the variety of firm types is notable. You have options ranging from traditional VCs to corporate partners and accelerators, allowing you to find a support structure that aligns with your company's needs.

As you prepare your fundraising strategy, Rho Capital can help you access non-dilutive financing to strengthen your position. After closing a round, our integrated platform provides the tools—from business banking to automated bill pay—to manage and deploy your capital effectively.

Raise Confidently with Rho

Fundraising requires significant time and focus, which is why a targeted list of investors is so important. We created this guide to help you connect directly with the right partners for your Health Diagnostics company.

If you’re seeking funding, Rho Capital connects you to non-dilutive funding options like venture debt and credit lines. Our team offers a fast, guided process to help you secure financing without distracting from your core work.

Once your capital is secured, Rho provides integrated tools to help you manage and deploy it efficiently. With business banking, corporate cards, and automated bill pay in one place, you can maintain full control of your finances.

FAQs about Venture Capital Firms Focused on Health Diagnostics

Which are the top healthcare venture capital firms in Boston?

Boston is a major center for health innovation. Firms like Catalyst Health Ventures and Broadview Ventures are key players, focusing on medical devices and diagnostics. They provide capital and access to a strong local life sciences network.

Are there European venture capital firms that invest in health diagnostics?

Yes, Europe has a growing number of VCs focused on health tech. Firms like Sofinnova Partners and Forbion are active in backing diagnostics and life science companies, offering access to European markets and regulatory expertise.

What do early-stage diagnostics VC firms look for?

Early-stage investors look for a strong scientific foundation, a clear IP strategy, and a large addressable market. Before you pitch, Rho Capital can help you access non-dilutive financing to strengthen your financial position.

Do biotech venture capital firms also invest in diagnostics?

Many biotech VCs do invest in diagnostics, especially if the technology has a strong biological or platform component. Firms like Genoa Ventures and Takeda Ventures often back companies at the intersection of biotechnology and diagnostics.

How can Rho help my startup manage its funding?

Once you secure funding, our integrated platform helps you manage it. With business banking, corporate cards, and automated bill pay in one place, Rho gives you the tools to control your finances and focus on growth.